ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,722Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 3647

$1.3M Total Retail Price of All Prescriptions

Rank: 114 out of 3647

891 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 891 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 891 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 20,422 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 894 731 1 1
AMLODIPINE BESYLATE 876 734 2 2
FUROSEMIDE 858 691 3 8
LISINOPRIL 850 687 4 4
GABAPENTIN 590 428 5 17
OMEPRAZOLE 543 463 6 3
HYDRALAZINE HCL 510 366 7 81
ATENOLOL 503 412 8 10
METFORMIN HCL 493 427 9 6
METOPROLOL TARTRATE 490 403 10 7
CAPTOPRIL 467 409 10 11 193
LEVOTHYROXINE SODIUM 452 342 12 5
HYDROCHLOROTHIAZIDE 450 331 13 9
CARVEDILOL 413 315 14 20
WARFARIN SODIUM 412 370 15 15
CLONIDINE HCL 403 270 16 46
HYDROCODONE-ACETAMINOPHEN 385 230 S3 17 12
GLIPIZIDE 377 303 18 41
TRAMADOL HCL 375 276 19 22
POTASSIUM CHLORIDE 360 267 20 24
OXYCODONE HCL-ACETAMINOPHEN 347 162 S2 21 104
NAPROXEN 333 236 22 70
ALPRAZOLAM 305 177 23 31
DONEPEZIL HCL 300 283 24 30
ATORVASTATIN CALCIUM 261 179 25 13
IBUPROFEN 246 196 26 55
MIRTAZAPINE 225 207 27 63
NOVOLIN R 225 168 27 139
TAMSULOSIN HCL 225 170 27 28
NIFEDIPINE ER 207 162 30 67
QUETIAPINE FUMARATE 201 180 31 89
OXYCODONE HCL 199 61 S2 32 75
ISOSORBIDE MONONITRATE ER 196 159 33 56
LANTUS 194 146 34 59
CITALOPRAM HBR 194 132 34 25
CLOPIDOGREL 186 126 36 26
FAMOTIDINE 177 142 37 61
RANITIDINE HCL 177 144 37 29
ZOLPIDEM TARTRATE 169 105 39 14
SERTRALINE HCL 157 121 40 27
ESCITALOPRAM OXALATE 154 126 41 65
TEMAZEPAM 152 102 42 47
RISPERIDONE 150 89 43 83
ENDOCET 150 79 S2 43 269
NAMENDA 148 146 45 49
KLOR-CON 8 146 134 46 264
PROAIR HFA 140 74 47 62
GLIPIZIDE ER 139 79 48 112
CIPROFLOXACIN HCL 135 102 49 53
PENICILLIN V POTASSIUM 128 58 50 490
PLAVIX 127 89 51 39
CLOTRIMAZOLE-BETAMETHASONE 127 110 51 84
KLOR-CON 10 126 102 53 106
METOPROLOL SUCCINATE 123 84 54 18
DIVALPROEX SODIUM 117 49 55 131
KLOR-CON M20 114 85 56 121
TRIAMTERENE-HCTZ 112 67 57 58
OXYCODONE-ACETAMINOPHEN 110 77 S2 58 91
TRAVATAN Z 106 72 59 293
MEGESTROL ACETATE 106 96 R 59 138
DIAZEPAM 106 72 59 214
FINASTERIDE 105 86 62 66
NIFEDICAL XL 101 72 63 221
AZITHROMYCIN 100 54 64 34
MECLIZINE HCL 98 75 65 85
DOXAZOSIN MESYLATE 98 85 65 57
TRAZODONE HCL 98 84 65 64
LEVETIRACETAM 97 67 68 122
INSULIN SYRINGE 97 75 68 76
DIGOXIN 97 80 68 51
ALBUTEROL SULFATE 96 80 71 157
FENTANYL 94 53 S2 72 147
ALENDRONATE SODIUM 93 77 73 23
BACLOFEN 86 43 74 97
LOSARTAN POTASSIUM 85 50 75 11
LANSOPRAZOLE 83 53 76 116
NOVOLOG MIX 70-30 83 66 76 261
OXYBUTYNIN CHLORIDE 82 53 78 107
GEMFIBROZIL 82 70 78 82
METHADONE HCL 79 29 S2 80 174
ENALAPRIL MALEATE 77 59 81 35
HUMULIN 70-30 76 48 82 192
MORPHINE SULFATE ER 76 13 S2 82 163
NEXIUM 76 62 82 44
JANTOVEN 76 61 82 140
IPRATROPIUM-ALBUTEROL 76 65 82 150
PANTOPRAZOLE SODIUM 76 54 82 38
LAMOTRIGINE 75 24 88 266
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 59 88 110
SYNTHROID 74 50 90 42
DETROL LA 74 66 90 292
CARBIDOPA-LEVODOPA 74 65 90 127
AMITRIPTYLINE HCL 73 58 R 93 105
CARISOPRODOL 73 0 R 93 115
ENOXAPARIN SODIUM 73 59 93 275
DORZOLAMIDE-TIMOLOL 71 49 96 391
FLUTICASONE PROPIONATE 69 53 97 32
FENOFIBRATE 68 31 98 50
ALLOPURINOL 68 63 98 37
LEVOFLOXACIN 68 57 98 87
HEPARIN SODIUM 68 57 98 351
RAMIPRIL 68 63 98 101
EXELON 67 66 103 129
BENZTROPINE MESYLATE 67 49 R 103 222
GENERLAC 66 43 105 278
CYMBALTA 65 29 106 79
ZETIA 64 54 107 96
SANTYL 63 49 108 233
METOCLOPRAMIDE HCL 62 32 109 135
PAROXETINE HCL 61 16 110 60
VERAPAMIL ER 61 52 110 99
SPIRONOLACTONE 61 38 110 77
NOVOLIN 70-30 60 57 113 130
NOVOLOG 59 35 114 123
INDOMETHACIN 58 24 R 115 355
DIOVAN 57 30 116 40
GLYBURIDE 56 41 R 117 54
PHENYTOIN SODIUM EXTENDED 56 22 117 199
PRAVASTATIN SODIUM 54 53 119 16
NITROFURANTOIN MONO-MACRO 54 40 119 268
LACTULOSE 53 44 121 128
MELOXICAM 52 45 122 33
AMIODARONE HCL 52 42 122 211
VOLTAREN 51 41 124 102
GENTAMICIN SULFATE 51 39 124 334
LIPITOR 51 38 124 113
BRIMONIDINE TARTRATE 50 38 127 361
TERAZOSIN HCL 50 50 127 103
LORAZEPAM 50 41 127 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.